These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24144739)

  • 1. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence factors on the formation of mammospheres from breast cancer stem cells].
    Huang MZ; Zhang FC; Zhang YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA
    Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].
    Lu YH; Zhu H; Wang ZW; Fan XJ; Zhu SJ; Li XH; Wang Y; Lu JJ; Zhu MY
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3107-10. PubMed ID: 22340650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
    Nami B; Donmez H; Kocak N
    Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
    Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
    Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox2 expression in breast tumours and activation in breast cancer stem cells.
    Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
    Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.